Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.
This segment of Dr. Kivitz’s interview at ACR 2023 featured a discussion about future research on TAK-279 as well as general outlook on the field for psoriatic arthritis.
Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing dallassun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallassun.com Daily Mail and Mail on Sunday newspapers.
Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.